MORPHOLINODOXORUBICIN HYDROCHLORIDE
UNII 4C093205SR

Substance Identification & Data

This profile provides standardized clinical and technical data for Morpholinodoxorubicin Hydrochloride, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4C093205SR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 89196-04-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4C093205SR

CAS Registry Number

89196-04-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MORPHOLINODOXORUBICIN HYDROCHLORIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C31H35NO12.ClH

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

INAUWOVKEZHHDM-PEDBPRJASA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C224423

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

174731

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

Cl.O([C@]1(C[C@@H]([C@@H]([C@@H](O1)C)O)N2CCOCC2)[H])[C@@H]3c4c(c(O)c5c(c4O)C(=O)c6c(C5=O)cccc6OC)C[C@](C3)(C(CO)=O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Morpholinodoxorubicin Hydrochloride. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

MORPHOLINODOXORUBICIN HYDROCHLORIDE

Systematic Nomenclature

5,12-NAPHTHACENEDIONE, 7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(2-HYDROXYACETYL)-1-METHOXY-10-((2,3,6-TRIDEOXY-3-(4-MORPHOLINYL)-.ALPHA.-LYXO-HEXOPYRANOSYL)OXY)-, HYDROCHLORIDE (1:1), (8S,10S)-

SYS

5,12-NAPHTHACENEDIONE, 7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METHOXY-10-((2,3,6-TRIDEOXY-3-(4-MORPHOLINYL)-.ALPHA.-LYXO-HEXOPYRANOSYL)OXY)-, HYDROCHLORIDE, (8S,10S)-

SYS

5,12-NAPHTHACENEDIONE, 7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METHOXY-10-((2,3,6-TRIDEOXY-3-(4-MORPHOLINYL)-.ALPHA.-LYXO-HEXOPYRANOSYL)OXY)-, HYDROCHLORIDE, (8S-CIS)-

SYS